A change to the Pharmaceutical Benefits Scheme listing for two key medicines, is a “big win for the macular disease community”.
Read MoreA change to the Pharmaceutical Benefits Scheme listing for two key medicines, is a “big win for the macular disease community”.
Read MoreThe federal today announced funding for MDFA to develop a Strategic National Action Plan for Macular Disease.
Read MoreThree leading macular disease researchers have been awarded $600,000 in research Macular Disease Foundation Australia grants.
Read MoreMDFA is celebrating World Sight Day 2017 with a further commitment of $600,000 into some of Australia’s leading research in macular disease.
Read MoreCheryl O’Reilly cares for her mother who has Charles Bonnet Syndrome. She shares her story of her mother’s diagnosis and how she copes.
Read MoreMDFA supports calls for the Commonwealth Bank to stop the roll out of touchscreen EFTPOS machines until accessibility issues are fixed.
Read MoreMDFA’s Low Vision report highlights the evidence base supporting the benefits of aids and technologies for those with vision loss and blindness.
Read MorePeople living in rural and remote areas needing sight-saving treatment will benefit from an important procedural change.
Read MoreGrand finalist and category winners of the mEYE World Photographic Competition 2016 announced to mark World Diabetes Day.
Read More